Your Interactive Roadmap
Follow the 9-chapter journey through the U.S. biomedical marketplace. Each chapter unlocks new insights and challenges.
Welcome to This Mini-Course
60.79% completion rate in the legacy course. Can you help beat it?
Why Develop New Drugs?
46.69% completion rate in the legacy course. Can you help beat it?
Where Do New Drugs Come From?
36.31% completion rate in the legacy course. Can you help beat it?
All About the Money! Venture Capital Investment in Biotech Innovation
31.35% completion rate in the legacy course. Can you help beat it?
Why New Drugs Are So Expensive (And Why Your $5 Generic Isnt)
27.52% completion rate in the legacy course. Can you help beat it?
The Journey from Brand to Generic and What Can Go Wrong
26.34% completion rate in the legacy course. Can you help beat it?
Why Insurance is So Important (and How it's Broken)
25.15% completion rate in the legacy course. Can you help beat it?
The Big Problems With Insurance (and How to Fix Them)
23.39% completion rate in the legacy course. Can you help beat it?
Confronting the Threat to US Biomedical Innovation
22.33% completion rate in the legacy course. Can you help beat it?
Wrapping It All Up!
22.17% completion rate in the legacy course. Can you help beat it?
Empowering the next generation of biotech leaders.
Biotech deals aren't just about science; they're about navigating a socio-economic contract. Learn from industry pioneer Peter Kolchinsky, Ph.D.
Certificate included
Earn recognition upon passing the final exam.
Career Growth
Understand the context you operate in to thrive.